Last quarter (Q0 0), Cytophage Technologies Ltd.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Cytophage Technologies Ltd.'s net income was $-1.09M. See Cytophage Technologies Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22
Total Revenue	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―
Operating Expense	$ 6.76M	$ 109.64K	$ 725.94K
Operating Income	$ -6.76M	$ -109.64K	$ -725.94K
Net Non Operating Interest Income Expense	$ 122.20K	$ 241.42K	$ 86.04K
Other Income Expense	$ 71.26K	$ 109.77K	$ 66.31K
Pretax Income	$ -6.71M	$ 22.01K	$ -706.21K
Tax Provision	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -5.70M	$ 22.01K	$ -706.21K
Basic EPS	$ -0.05	$ ―	$ ―
Diluted EPS	$ -0.06	$ ―	$ ―
Basic Average Shares	$ 182.38M	$ 25.00M	$ ―
Diluted Average Shares	$ 186.73M	$ 26.09M	$ ―
Dividend Per Share	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―
Total Expenses	$ 4.39M	$ ―	$ 725.94K
Net Income From Continuing And Discontinued Operation	$ -5.70M	$ 22.01K	$ -706.21K
Normalized Income	$ -6.62M	$ 16.18K	$ -519.06K
Interest Expense	$ ―	$ ―	$ ―
EBIT	$ -5.63M	$ 22.01K	$ -706.21K
EBITDA	$ -5.10M	$ 22.01K	$ -706.21K

Currency in USD

Cytophage Technologies Ltd. Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing